Status:
RECRUITING
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Lead Sponsor:
Friendi.fi Corporation
Collaborating Sponsors:
Dana-Farber Cancer Institute
care.coach corporation
Conditions:
Hematopoietic Stem Cell Transplantation
Cancer
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ cont...
Detailed Description
Allogeneic hematopoietic stem cell transplantation (HCT) is the delivery of multipotent donor-derived stem cells to a recipient patient. It typically involves a lengthy inpatient hospitalization (medi...
Eligibility Criteria
Inclusion
- Age 18+
- Seen for outpatient RIC HCT (prior to D0, generally D-6).
Exclusion
- Deemed by clinical staff or research assistant (RA) to be unable to converse with an avatar, due to: severe, uncorrectable hearing or vision impairment; severe speech impairment that precludes understanding by staff (or by the avatar).
- Not fluent in English.
Key Trial Info
Start Date :
October 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06564233
Start Date
October 21 2024
End Date
June 30 2026
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215